Upregulation of Bcl2 in NSCLC with acquired resistance to EGFR-TKI

Lung cancer has the highest incidence and mortality rate worldwide among all malignancy-associated mortalities, of which non-small cell lung cancer accounts for 80% of all cases. Resistance against epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) develops following 8–12 months...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncol Lett
Hlavní autoři: Cheong, Hio Teng, Xu, Fei, Choy, Chi Tung, Hui, Connie Wun Chun, Mok, Tony Shu Kam, Wong, Chi Hang
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2018
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5772989/
https://ncbi.nlm.nih.gov/pubmed/29422965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7377
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky